Lastly, the contribution of sEng and the TGF-β pathway to the anti-angiogenic component in preeclampsia’s pathophysiology is acknowledged, but despite this body of evidence, the effects at level of the brain vasculature require further characterization. The gene discussed is TGFB1; the disease is preeclampsia.